Columbia Labs Shares Are A Speculative Buy Here
Shares of Columbia Laboratories once again took a beating yesterday, cut by more than half, after a negative 13-4 vote by the FDA Advisory Committee on Friday after-hours, recommending against approving its progesterone vaginal gel 8% Prochieve in reducing the risk of pre-term birth in women with a single gestation and a short uterine cervical ... (more)